According to a recent study published in "Annals of Rheumatic Diseases" Journal, Pharmaceutical-grade Chondroitin sulfate (800mg/day) was found to possess similar efficacy as celecoxib in managing Knee Osteoarthritis (OA).
The results of the latest study demonstrated the effectiveness of Leflunomide (LEF) in arthritis patients with failed methotrexate response. The investigators found LEF to be devoid of serious adverse effects and it can be considered a reasonable and cost-effective treatment option before initiating biological therapy.
The customizable thin insoles provided a significant reduction in pain produced by walking, confirms the recent study published in "Musculoskeletal care" Journal.
A recent study published in "Arthritis Care and Research" revealed that the combination of ITGβ5, M2BP, and C-Reactive protein (CRP) level distinguishes psoriatic arthritis (PsA) from those with psoriasis without psoriatic arthritis (PsC). Also, the combination was found to be better than CRP level alone.
“Patient navigators do not ameliorate oral DMARD adherence”, confirms latest study published in Arthritis Care & Research Journal
- 1 of 147